FdaApplication
ANDA 201802
Identifiers
- fda_app_no: ANDA201802
Properties
| Property | Value |
|---|---|
| applicant_name | CHARTWELL RX SCIENCES LLC |
| application_type | ANDA |
| approval_date | 2023-10-03 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 600MG | TABLET;ORAL |
| EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 600MG;200MG;300MG | TABLET;ORAL |
| EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE | 300MG | TABLET;ORAL |
3 products